These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22877915)

  • 1. Melting heart: dilated phase of hypertrophic cardiomyopathy.
    Canpolat U; Şahiner L; Kaya EB; Aytemir K
    Anadolu Kardiyol Derg; 2012 Oct; 12(7):E36-7. PubMed ID: 22877915
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of defibrillator to synchronise during external cardioversion of atrial fibrillation.
    Loudon M; Deakin CD
    Resuscitation; 2009 Apr; 80(4):500-1. PubMed ID: 19231062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
    Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disheartening Disparities.
    Kidia KK
    N Engl J Med; 2016 Mar; 374(10):909-11. PubMed ID: 26962726
    [No Abstract]   [Full Text] [Related]  

  • 6. Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
    Katsiyiannis WT; Waggoner AD; Barzilai B; Gage BF; Sanchez JM; Rogers JG; Lindsay BD; Gleva MJ
    Am J Cardiol; 2005 Jan; 95(2):286-8. PubMed ID: 15642573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of stress echocardiography in the study of patients with dilated or hypertrophic cardiomyopathy.
    Wu WC; Bhavsar JH; Aziz GF; Sadaniantz A
    Echocardiography; 2004 Jul; 21(5):467-75. PubMed ID: 15209731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disease progression and systolic dysfunction in patients with hypertrophic cardiomyopathy: genetic basis, pathophysiology and clinical presentation].
    Poggesi G; Ferrantini C; Servettini E; Girolami F; Cecchi F; Olivotto I
    G Ital Cardiol (Rome); 2011 Dec; 12(12):815-23. PubMed ID: 22158452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic cardiomyopathy: a genetically-carried heart disease].
    van Dockum WG; Doevendans PA; van Rossum AC; Wilde AA
    Ned Tijdschr Geneeskd; 2002 Apr; 146(15):705-12. PubMed ID: 11980370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Images in cardiovascular medicine. Electroanatomic mapping of cardiac resynchronization therapy.
    Reddy VY; Neuzil P; Taborsky M; Kralovec S; Sedivá L; Ruskin JN
    Circulation; 2003 Jun; 107(21):2761-3. PubMed ID: 12782617
    [No Abstract]   [Full Text] [Related]  

  • 12. Late gadolinium enhancement cardiac magnetic resonance imaging in prognostic assessment of hypertrophic cardiomyopathy.
    Bouabdallaoui N; Ennezat PV; Durand E; Puymirat E; Macron L
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):1024. PubMed ID: 23644935
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of indications for cardiac resynchronisation therapy in the implantable cardioverter defibrillator population.
    Paisey JR; Yue AM; Moore R; Betts TR; Roberts PR; Morgan JM
    Int J Cardiol; 2005 Mar; 99(2):187-90. PubMed ID: 15749173
    [No Abstract]   [Full Text] [Related]  

  • 14. Syncope in congestive heart failure.
    Gopinathannair R; Mazur A; Olshansky B
    Cardiol J; 2008; 15(4):303-12. PubMed ID: 18698538
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective.
    Cleland JG; Cullington D; Khaleva O; Tageldien A
    Curr Opin Cardiol; 2008 Nov; 23(6):634-45. PubMed ID: 18830081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gamma-scintigraphy in assessment cardioresynchronizing therapy at chronic heart failure].
    Minin SM; Chernov VI; Savenkova GM; Lishmanov IuB
    Klin Med (Mosk); 2008; 86(5):24-7. PubMed ID: 18589712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A contemporary approach to hypertrophic cardiomyopathy.
    Ho CY; Seidman CE
    Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.
    Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D
    Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial restrictive cardiomyopathy with 12 affected family members.
    Daneshvar DA; Kedia G; Fishbein MC; Siegel RJ
    Am J Cardiol; 2012 Feb; 109(3):445-7. PubMed ID: 22071211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.